Abstract:Previous studies have confirmed that both recombinant human erythropoietin (rhEPO) and peroxisome proliferator-activated receptors γ (PPARγ) activator pioglitazone can protect senescent nerve cells, and their mechanisms involve enhancing cell antioxidant capacity and reducing cell apoptosis. However, whether the PPARγ pathway is involved in the rhEPO anti-aging process in neuronal cells is still unclear. In this study, to explore the relationship between rhEPO and the PPARγ pathway at the cellular level, primary nerve cells cultured for 22 days were used to simulate the natural aging process of nerve cells. Starting on the 11th day of culture, rhEPO, LY294002, and GW9662 were added for treatment. Immunochemical methods and SA-β-gal staining were used to observe the changes in cellular antioxidant capacity and the fraction of senescent cells. The results showed that PPARγ blockade retarded the effect of rhEPO on the cellular antioxidant capacity and altered the fraction of senescent cells. It was confirmed that PPARγ was involved in rhEPO's anti-aging process in neuronal cells. Real-time fluorescent quantitative RT-PCR, Western blotting, and immunofluorescence staining were used to observe the changes in PPARγ pathway–related factors in nerve cells after rhEPO treatment. The results showed that rhEPO significantly upregulated the expression of PPARγ coactivator-1α (PGC-1α), PPARγ, and nuclear PPARγ in cells but did not affect the level of phosphorylated PPARγ protein, confirming that rhEPO has the ability to upregulate the PPARγ pathway. PI3K/Akt and PPARγ pathway blockade experiments were used to explore the relationships among rhEPO, PI3K/Akt, and PPARγ. The results showed that after PPARγ blockade, rhEPO had no significant effect on the PI3K/Akt pathway–related factor p-Akt, while after PI3K/Akt blockade, rhEPO's effects on PPARγ-related factors (PGC-1α, PPARγ, and nuclear PPARγ) were significantly decreased. It is suggested that rhEPO delays the PI3K/Akt pathway in the process of neuronal senescence, which is located upstream of PPARγ regulation. In conclusion, this study confirmed that rhEPO can upregulate the expression of PGC-1α and PPARγ in cells and the level of PPARγ protein in the nucleus to enhance the antioxidant capacity of cells and delay the senescence of nerve cells through the PI3K/Akt pathway. These findings will provide ideas for finding new targets for neuroprotection research and will also provide a theoretical basis and experimental evidence for rhEPO anti-aging research in neural cells.

The Anti-Aging Effect of Erythropoietin Via the ERK/Nrf2-ARE Pathway in Aging Rats

Erythropoietin Suppresses D-galactose-induced Aging of Rats Via the PI3K/Akt/Nrf2-ARE Pathway

The Anti-aging Effect of EPO and the Preliminary Probe into Its Mechanisms

[Effect of Erythropoietin on Activities of Antioxidant Enzymes in the Brain Tissue of Aged Rats].

Antioxidant capacities of long-range cultured neurons enhanced by erythropoietin ( EPO )-regulated Nrf 2 pathway

Rhepo Affects Apoptosis in Hippocampus of Aging Rats by Upregulating Sirt1

[Effects of Recombinant Human Erythropoietin on Brain-Derived Neurotrophic Factor Expression in Different Brain Regions of Aging Rats].

rhEPO Enhances Cellular Anti-oxidant Capacity to Protect Long-Term Cultured Aging Primary Nerve Cells

rhEPO Upregulates the PPARγ Pathway in Long-term Cultured Primary Nerve Cells via PI3K/Akt to Delay Cell Senescence

Recombinant human erythropoietin protects long-term cultured ageing primary nerve cells by upregulating the PI3K/Akt pathway

Erythropoietin ameliorates diabetes-associated cognitive dysfunction in vitro and in vivo

The Protective Effect of Adiponectin-Transfected Endothelial Progenitor Cells on Cognitive Function in D-Galactose-Induced Aging Rats

Recombinant Human Erythropoietin Upregulates PPARγ Through the PI3K/Akt Pathway to Protect Neurons in Rats Subjected to Oxidative Stress.

Erythropoietin Attenuates Alzheimer-like Memory Impairments and Pathological Changes Induced by Amyloid Β42 in Mice

Leonurine ameliorates D-galactose-induced aging in mice through activation of the Nrf2 signalling pathway

Erythropoietin Improves Neurobehavior by Reducing Dopaminergic Neuron Loss in a 6-Hydroxydopamine-induced Rat Model

Alginate Oligosaccharide Ameliorates D-Galactose-Induced Kidney Aging in Mice through Activation of the Nrf2 Signaling Pathway

Intranasal Erythropoietin Ameliorates Neurological Function Impairments and Neural Pathology in Mice with Chronic Alcoholism by Regulating Autophagy‑related Nrf2 Degradation.

Erythropoietin Prevents PC12 Cells from Beta-Amyloid-induced Apoptosis Via PI3K⁄Akt Pathway

An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer's Disease

Influences and mechanism of erythropoietin on the cognitive function of vascular dementia rats